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INTRODUCTION
Breast cancer is the most common cancer in women
and women living in North America have the highest
rate of breast cancer in the world. The incidence of
breast cancer has been steadily rising, making it one of
the leading causes of cancer mortality in women world-
wide [1]. Incidence of breast cancer in India found to be
20.01 per 100000 women and 0.26 per 100000 men
[2].
The treatment of breast cancer is mul modal. The
treatment of stage I and stage II disease is standardized
in the form of surgery ± Hormonal therapy ± Adjuvant
Chemotherapy or Radiotherapy.
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However management of advanced breast cancer is
always evolving.  New clinical ques ons have emerged
regarding surgery of the primary site in those women
with metasta c disease and a resectable intact primary
tumour [3].
Surgical treatment of the intact primary in pa ents
diagnosed with stage IIIb and IV breast cancer is gener-
ally reserved for pallia ve indica ons-bleeding, tumour
ulcera on, infec on and hygienic considera ons [4]. In
1943, Haagensen and Stout [5] published their criteria
of inoperability for carcinoma of the breast, which hold
true today when considering a resec on for cura ve
intent.
The criteria include tumour fixa on to the chest wall,
ulcera on and peau d’orange, features considered to
be grave prognos c signs. Surgical treatment alone is
unlikely to prolong life in pa ents who possess these
grave signs.
Various studies have been done on the role of surgery
in advanced breast cancer. There have been significant
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difference in life span of pa ents who underwent re-
sec on of tumour as compared to those who were not
operated [6-11]. On the other hand, two inves ga ons
suggested that the removal of the primary tumour
might not improve survival for metasta c breast cancer
[12, 13].
Aim & Objec ve: To study the treatment modali es in
pa ents with advanced cancer breast (stage IIIb and
stage IV) with or without ini al Chemo-Hormono-
Radiotherapy at Pravara Rural Hospital, Loni.
MATERIALS AND METHODS
Study design: This prospec ve observa onal study
Ethics approval: from our ins tu onal ethical com-
mi ee was obtained before ini a on of the study.
Study loca on: The study was carried out in Pravara
Rural Hospital in the Department of Surgery
Study period: May 2015 to March 2017.
Sample size: The study included 100 pa ents.
Inclusion criteria: All the pa ents with stage IIIb and
stage IV Breast cancer sa sfying the inclusion and ex-
clusion criteria were included in the study. Histological-
ly and pathologically proven carcinoma of breast with
stage IIIb and IV and who underwent/undergoing sur-
gery in stage IIIb ± ini al Chemo-Hormono-
Radiotherapy or who underwent/undergoing surgery
(Pallia ve Mastectomy) ± LN dissec on or MRM in
stage IV ± ini al Chemo-Hormono-Radiotherapy were
included in the study.
Exclusion criteria: Pa ents of stage I, stage II and stage
IIIa Breast cancer, who did not undergo surgery and
those who had performance status of 3 or 4, were ex-
cluded from the study.
Methodology
Data regarding personal par cular like name, age, sex,
caste, educa on,socio-economic status, chief com-
plaints, past medical history, menstrual history, obstet-
ric history ,breast feeding history,  were collected by
interviewing pa ents under study and their rela ves
with the help of pretested and predesigned proforma.
Informa on regarding family history of similar com-
plaints, opera ve detailed history, treatment received
by the pa ents was recorded also recorded. Postopera-
vely pa ents were followed up every monthly for
comple on Chemotherapy and clinical examina on for
first 3 months than 3 monthly interval. Pa ents were
thoroughly examined for local site or Axillary recur-
rence and progress of the disease in the form of supra-
clavicular lymph node, opposite breast, arm edema,
bony tenderness, chest infec on and liver enlarge-
ment.
RESULTS
The study included 100 pa ents. 90 pa ents were
women while 10 were men. The mean age of pa ents
was 56.8 years. Of these, 28% of pa ents were of 61-70
years of age, While 20% of pa ents were at 41-50 years
of age. Most of the pa ents were postmenopausal ie.
78, while 12 were premenopausal. Of the 90 women,
15 were nulliparous. Out of 90 pa ents, 75 had history
of breast feeding. All pa ents presented with lump in
the breast while 10 pa ents complained of pain and 7
complained of discharge. Right, le  and bilateral in-
volvement of breast was seen in 33, 65 and 2 pa ents
respec vely. Upper and outer (72) followed by central
(37) were the most common quadrants involved in the
breast cancer.
Figure 1: Age wise distribu on of pa ents
Figure 2: Stage wise distribu on of pa ents
Pa ents with stage IIIb disease comprised of 80% of
total cases, while stage IV pa ents comprise only 5%.
Remaining 12% of pa ents were of regional LN enlarge-
ment and 3% of local recurrence. Axillary lymph nodes
were clinically palpable in 82 pa ents. The nodal status
was N0, N1 and N2 in 17, 33 and 27 pa ents respec ve-
ly. Histology of postopera ve axillary lymph nodes
showed that 70 out of 100 were lymph node posi ve.
Table 1: Axillary lymph node status by clinical exami-
na on, Histopathology and staging
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Clinically
Palpable
Axillary
nodes
Histopatholo-
gy Positive
Nodal
status
Present in
patients
82 70 N0 -17,
N1 -33,
N2 -27,
N3 -23
Absent in Pa-
tients
18 30
Total 100 100 100
91
Figure 3: Histopathological Report types of specimen
Figure 4: Surgical treatment used in patients
Five  pa ents who underwent pallia ve mastectomy
with/without lymph node excision includes 1 (20%)
case of stage IV breast cancer with funga ng mass; 3
cases(60%) who refused Neo-adjuvent Chemotherapy
and later on came with local complica ons as funga ng
mass with secondary infec on. One pa ent received
Neoadjuvent Chemotherapy.
One pa ent with stage IV disease with funga ng mass
with mobile axillary lymph nodes underwent pallia ve
mastectomy with complete axillary clearance.
Out of 5 pa ents who underwent pallia ve mastecto-
my, 3 pa ents who were presented with local compli-
ca ons (ulcera on/ funga on/ bleeding/ infec on)
axillary clearance was not done.
One pa ent who came with local complica ons re-
ceived Neoadjuvent chemotherapy+Radiotherapy. This
pa ent underwent pallia ve mastectomy with axillary
clearance upto Level I as Level II lymph nodes found to
have fixed intraopera vely.
Out of 100 pa ents, 58 received Neoadjuvant Chemo-
therapy. Among the pa ents who did not receive Neo-
adjuvant Chemotherapy (42), 21 were locally operable,
15 were operated outside while 7 had local complica-
ons
Figure 5:  Distribu on of pa ents who received Chem-
otherapy (CT)
77 pa ents completed all 6 Chemotherapy cycles.
Among the all pa ents, 70 received Radiotherapy.
Figure 6: Post-operative complications observed in
the patients.
As per our study 25% of pa ents developed cough pro-
gressing to the pleural effusion (33%), 22% of cases
developed palpable Axillary nodes during the period of
follow up, 35% developed supraclavicular lymph node
enlargement. Ultrasonographically liver secondaries
were found in 12% of cases while one case i.e.3 % of
pa ents developed contralateral breast cancer for
which pa ents underwent Modified Radical mastecto-
my with Axillary clearance. 47% of our pa ents were
symptom free during the course of follow up.
Out of total pa ents of follow up, 10% of pa ents fol-
lowed up for less than 6 months, 33% of pa ents fol-
lowed up for 7-12 month interval, 40% of cases fol-
lowed up for 13 to 24 months dura on while 2% of
cases followed up to 24-30 months dura on. 6 pa ents
died during the course of follow up i.e.15%. However
this study was of short dura on to comment on post-
opera ve outcome a er surgery in advanced breast
cancer.
Int. j. clin. biomed. res. 2017;3(4S):89-95
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DISCUSSION
Oncology has evolved in leaps and bounds and is s ll
evolving. Carcinoma of breast is the commonest malig-
nancy in females and that too in post-menopausal age
group with rising trend of incidence almost all over the
world [14].
Breast cancer is systemic disease when it is clinically
palpable. Mechanism of lympha c /local /blood born
metastases was well understood today and we know
how the disease spreads. Metasta c breast cancer is
usually associated with the worst prognosis; an average
survival of 1-2 years is expected in case of visceral me-
tastases. This common belief has resulted in treatment
regimens based on the no on that pallia ve manage-
ment is the op onal choice for stage IIIb and stage IV
pa ents. This conven onal doctrine assumes that both
excision of symptoma c and asymptoma c stage IIIb
and stage IV disease are unlikely to offer the pa ent
any survival benefit [15].
According to WHO reports from the Interna onal Agen-
cy for Research on Cancer (IARC), the incidence of the
disease is mainly above the age of 40 years. Similar
findings have been noted by the Poona Cancer Registry
showing more than 66% cases above the age of 40
years during 1981-1985 [16].
As per our study, higher incidence of breast cancer was
found in age group 51-60 (32.5%) which corresponds
well to the established studies. At the extremes of the
age, significantly lower incidence was recorded with no
pa ents below the age of 30 years. Bhaskar et al
(1970), Lane Clyppon (1982), Jude (1912), Primorose
(1912), Jussawal (1950), all have men oned the maxi-
mum incidence of breast cancer in between 40-60
years of age [17-19].
The incidence of male breast cancer varies from 0.2 to
0.6% [20]. On the contrary our study has showed 10%
incidence (10 out of 100 cases)   of male breast cancer.
Increased incidence of male breast cancer could be
because of change in trend of carcinoma of breast, un-
derreported female pa ents, smaller sample size.
During the course of our study, we came across total 60
cases of breast cancer, out of which 85 pa ents have
stage IIIb and stage IV disease,  out of  81 pa ents
were of stage IIIb disease and 4 pa ents of stage IV
disease.
The reasons of larger incidence of higher stage breast
cancer in female popula on at the me of presenta on
can be many folds. There can be inhibi on due to social
customs, Unawareness of the disease or Ignorance of
the disease.
Our study shows that incidence of disease is higher i.e.
78 out of 90 (86.6%) in postmenopausal women than
premenopausal i.e.13.4% which corresponds well with
the established studies. As per our study, 16.6% (15 out
of 90) of total pa ents were nulliparous women, ex-
plaining it as a risk factor.
86% pa ents in our study had a history of breast feed-
ing. Breast feeding has shown to have a protec ve in-
fluence against breast cancer [21]. Contrary to this we
found increased incidence of breast cancer in breast
fed women.
In our study, preponderance was seen on the le  side
which was involved in 65% and right side in 33% of cas-
es. As per Paul PR, breast cancer shows a predilec on
for le  side (52%) than right (48%) [22]. Bilateral cancer
was found in 2% of cases in our study.
In our study, upper outer quadrant was the most fre-
quent site of disease progression.  Percentage wise
distribu on shows upper outer quadrant involvement
(72%), central quadrant (37%) and upper inner and
lower outer quadrant in 20% and 12% of cases respec-
vely while lower inner quadrant and axilla showed
10% of cases each. Spra  J., Donegan W reported 48%
of tumour in upper outer quadrant, 17% in central re-
gion, 15% in upper inner quadrant, 11% in lower outer
quadrant and 6% in lower inner quadrant [23].
In the present study, 100% pa ent popula on present-
ed with lump as their primary symptom, while only
10% pa ents had complaints of pain and 7% had com-
plaints of discharge as associated symptoms. This is
contrary to the findings of Roger G. reported presence
of lump in 50% of cases and discharge in 35% of cases
[24].
In our study, we found about 18% of cases in which no
clinically apparent lymph node involvement was pre-
sent. Histopathologically (post-opera ve) 30% were
node nega ve i.e. lymph nodes in these cases not
showed evidence of tumour ssue. This means that
axillary lymph nodes responded very well to Neoad-
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Table 2: Summary of treatment received by the patients
Type of Treatment NeoadjuvantChemotherapy
Surgical
closure
Axillary Lymph
node removal
Chemo
therapy
Radio
Therapy
Number of pa ents Treat-
ment received 58 92
Complete clear-
ance- 80
Clearance upto
level I-12
Total- 92
CMF-85
CAF- 15 70
Number of pa ents Treat-
ment NOT received 42 8 8 0 30
Total 100 100 100 100 100
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juent Chemotherapy. This results in be er locoregional
control with resultant good postopera ve outcome.
Out of 100 pa ents,30 pa ents were clinically node
nega ve. 33 pa ents were having N1 nodal status. N2
nodal status was present in 27 pa ents while remaining
23 pa ents were having N3 (along with N2) nodal sta-
tus. Our clinical findings of node nega ve status corre-
lates postopera vely in the form of 30 node nega ve
pa ents having histopathological node nega ve status.
In our study, we found Invasive ductal carcinoma in 95%
of cases; Invasive papillary and Adenoid cys c carcino-
ma were noted in 3% and 2% respec vely. Medullary
and Lobular carcinoma was not recorded at
all.GallagerH.S. reported Infiltra ng ductal carcinoma as
the most frequent type of all carcinomas o reast ,
comprising nearly 75% of all cases [25].
The management of locally advanced breast cancer was
a tough challenge in the past, but with the evolu on of
various treatment modali es it is possible to achieve a
prolonged disease free survival and be er quality of
life. Thus over a period of me mul modality approach
(including surgery ± Chemotherapy ± Radiotherapy ±
Hormonal therapy) in the treatment of locally advanced
breast cancer has become gold standard [26].
In our study 73 pa ents underwent Modified Radical
Mastectomy with Axillary clearance. 7 pa ents under-
went Pallia ve Mastectomy, and pa ents also under-
went lymph node excision along with Pallia ve Mastec-
tomy.
While 12 cases underwent Axillary clearance for theirre-
gional Lymph node enlargement. Two pa ents who
came with local recurrence underwent wide local exci-
sion with axillary clearance.
As per our study, out of 58 cases receiving Neoadjuvent
Chemotherapy, 54 cases i.e.92.5% of cases showed par-
al response i.e. 50% or greater reduc on in sum of
products of the perpendicular diameters of measurable
disease and no appearance of a new malignant lesion
for a minimum of 4 weeks, remaining 4 cases i.e.7% of
cases showed stable disease i.e. No appearance of new
areas of disease or less than 50% decrease or less than
25% increase in the described measurements. None of
the cases has shown complete response or progressive
disease.
Good chemotherapy response of local site as well as
regional site gives good locoregional control. In our
study, histopathologically (post-opera ve) 30% were
node nega ve i.e. lymph nodes in these cases not
showed evidence of tumour ssue. This means that
axillary lymph nodes responded very well to Neoad-
juent Chemotherapy. This results in be er loco-regional
control with resultant good postopera ve outcome.
In the present study, 85% of cases in our study were
given CMF regimen while remaining 15% of pa ents
were given CAF regimen. The schedules were as fol-
lows: CMF day 1 and day 8 and CAF for day 1 only and
each one repeated 3 weekly. Cycles were given un l
response to them became sta c or evidence of progres-
sive disease.
Coskun U et al evaluated locally advanced breast
cancer pa ents who had been treated with differ-
ent Neoadjuvent Chemotherapy regimens, viz. CAF
( Cyclophosphamide, Doxorubicin, 5-Fluorouracil),
CA (Cyclophosphamide, Doxorubicin), FEC (5-
Fluorouracil, Epirubicin, Cyclophosphamide) ,CE
(Cyclophosphamide, Epirubicin) and with CMF
(Cyclophosphamide, Methotrexate, 5-Fluorouracil)
combina on in Neoadjuvent se ngs. In their
study, overall response rates were found to be
higher in Anthracyclin based combina ons than
CMF, but these regimens had no addi onal survival
advantage over CMF regimen. They recommended
that the long –term effects of these regimens
should be inves gated in further randomized trials
[27].
We found the regimen CMF is cheaper (Rs 370/
cycle) and effec ve and hence well accepted by
poor popula on of rural India.77 pa ents were
able to complete all 6 Chemotherapy cy-
cles.Remaining pa ents either taken only single
cycle (2%) , only two cycles (2%), only three cycles
(5%); some able to con nue only four Chemothera-
py cycles (12%) and then dropped out.
70 pa ents received radiotherapy in the present
study. Radiotherapy as an approach in Locally ad-
vanced breast cancer has been studied by Dalena
et al as early as 1978 [28] and more recently stud-
ied in the primary management of regionally con-
fined breast cancer by Fletcher G in 1985 [29]. Grim
KL studied the role of adjuvant radiotherapy fol-
lowed by chemotherapy in breast cancer pa ents
treated with mastectomy [30].
22% of cases developed palpable Axillary nodes
during the period of follow up. The reasons for pal-
pable axillary lymph node even a er axillary clear-
ance might be due to residual disease, micrometas-
tasis, non-responders to chemo-radiotherapy, ag-
gressive tumour or lodging of tumour cells.
Limita on of the study: Being an academic thesis,
our study was carried for a period of 2 years. This is
the main limita on of the study as most of the cas-
es were s ll under follow up and observa on.
Sugges on: During our study we noted a startling
fact of higher incidence of breast cancer in mul pa-
rus and breast fed women in rural popula on. This
is contrary to our standard learning. This par cular
fact needs to be studied in the context with rural
popula on.
There is a definite role of surgery in advanced
breast cancer. Hence efforts should be taken to
convince the importance of not only Neoadjuvent
but also   post-opera ve therapy to the pa ents
and their rela ves thereby increasing the compli-
ance and involvement of pa ent in treatment along
with health educa on and awareness.
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CONCLUSION
Problems in rural popula on are mul focal. 50% of our
pa ents presented with advanced breast cancer. 15%
pa ents ran away from the ward. 25% pa ents did not
complete postopera ve treatment (Chemo-
Radiotherapy). So even though cancer treatment is a
team work, general surgeon in a rural popula on has to
shoulder the addi onal responsibility of an oncologists,
psychologists, plas c surgeons and counselor. All this
together will lead to an early and effec ve treatment of
advanced malignancy, long disease-free interval and
be er quality of life in a rural popula on..
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